Orally administered EB-373 resulted in dose-dependent increase in psilocin blood concentration in pharmacokinetic (PK) animal studies, correlating to levels expected to be effective based on psilocybin data in humans Outcome of animal studies indicate potential to reduce GI upset and vomiting as well as rapid onset of action and systemic clearance, improving on PK characteristics […]
Taiwan FDA plans to remove animal studies for tooth health products
The regulator said on August 17 that it was seeking public feedback in the next 60 days on the recommendations that it has made. In Taiwan, health foods that make oral health claims can state the following “helps to increase the pH value of dental plaque in the oral cavity”, “helps to reduce the accumulation […]